Search Results

There are 10329 results for: content related to: Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers

  1. Sublingual Buprenorphine as an Analgesic in Chronic Pain: A Systematic Review

    Pain Medicine

    Volume 15, Issue 7, July 2014, Pages: 1171–1178, Joyce Cote and Lori Montgomery

    Version of Record online : 4 JUL 2014, DOI: 10.1111/pme.12386

  2. Buprenorphine

    Medical Toxicology of Drug Abuse: Synthesized Chemicals and Psychoactive Plants

    Donald G. Barceloux, Pages: 514–526, 2012

    Published Online : 2 FEB 2012, DOI: 10.1002/9781118105955.ch28

  3. Pharmacokinetics and Pharmacodynamics of Multiple Sublingual Buprenorphine Tablets in Dose-Escalation Trials

    The Journal of Clinical Pharmacology

    Volume 46, Issue 2, February 2006, Pages: 179–192, Dr Domenic A. Ciraulo, Dr Robert J. Hitzemann, Dr Eugene Somoza, Dr Clifford M. Knapp, Dr John Rotrosen, Dr Ofra Sarid-Segal, Ms Ann Marie Ciraulo, Dr David J. Greenblatt and Dr C. Nora Chiang

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270005284192

  4. Population Pharmacokinetic Model of Sublingual Buprenorphine in Neonatal Abstinence Syndrome

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 35, Issue 7, July 2015, Pages: 670–680, Chee M. Ng, Erin Dombrowsky, Hopi Lin, Michelle E. Erlich, David E. Moody, Jeffrey S. Barrett and Walter K. Kraft

    Version of Record online : 14 JUL 2015, DOI: 10.1002/phar.1610

  5. You have free access to this content
    Buprenorphine for treating cancer pain

    Intervention Review

    The Cochrane Library

    Mia Schmidt-Hansen, Nathan Bromham, Mark Taubert, Stephanie Arnold and Jennifer S Hilgart

    Published Online : 31 MAR 2015, DOI: 10.1002/14651858.CD009596.pub4

  6. You have free access to this content
    Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence

    Intervention Review

    The Cochrane Library

    Richard P Mattick, Courtney Breen, Jo Kimber and Marina Davoli

    Published Online : 6 FEB 2014, DOI: 10.1002/14651858.CD002207.pub4

  7. You have full text access to this OnlineOpen article
    Rifampicin decreases exposure to sublingual buprenorphine in healthy subjects

    Pharmacology Research & Perspectives

    Volume 4, Issue 6, December 2016, Nora M. Hagelberg, Mari Fihlman, Tuija Hemmilä, Janne T. Backman, Jouko Laitila, Pertti J. Neuvonen, Kari Laine, Klaus T. Olkkola and Teijo I. Saari

    Version of Record online : 3 NOV 2016, DOI: 10.1002/prp2.271

  8. Abuse potential of intranasal buprenorphine versus buprenorphine/naloxone in buprenorphine-maintained heroin users

    Addiction Biology

    Volume 20, Issue 4, July 2015, Pages: 784–798, Jermaine D. Jones, Maria A. Sullivan, Suzanne K. Vosburg, Jeanne M. Manubay, Shanthi Mogali, Verena Metz and Sandra D. Comer

    Version of Record online : 24 JUL 2014, DOI: 10.1111/adb.12163

  9. Conversion from High-Dose Full-Opioid Agonists to Sublingual Buprenorphine Reduces Pain Scores and Improves Quality of Life for Chronic Pain Patients

    Pain Medicine

    Volume 15, Issue 12, December 2014, Pages: 2087–2094, Danielle Daitch, Jonathan Daitch, Daniel Novinson, Michael Frey, Carol Mitnick and Joseph Pergolizzi Jr

    Version of Record online : 12 SEP 2014, DOI: 10.1111/pme.12520

  10. Buprenorphine TTS for children – a review of the drug’s clinical pharmacology

    Pediatric Anesthesia

    Volume 21, Issue 3, March 2011, Pages: 280–290, Erik Michel, Brian J Anderson and Boris Zernikow

    Version of Record online : 21 NOV 2010, DOI: 10.1111/j.1460-9592.2010.03437.x

  11. Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine

    European Journal of Pain

    Volume 13, Issue 3, March 2009, Pages: 219–230, Hans G. Kress

    Version of Record online : 9 JAN 2012, DOI: 10.1016/j.ejpain.2008.04.011

  12. Current Knowledge of Buprenorphine and Its Unique Pharmacological Profile

    Pain Practice

    Volume 10, Issue 5, September/October 2010, Pages: 428–450, Joseph Pergolizzi, Anna Maria Aloisi, Albert Dahan, Joerg Filitz, Richard Langford, Rudolf Likar, Sebastiano Mercadante, Bart Morlion, Robert B. Raffa, Rainer Sabatowski, Paola Sacerdote, Luis M. Torres and Avi A. Weinbroum

    Version of Record online : 17 MAY 2010, DOI: 10.1111/j.1533-2500.2010.00378.x

  13. The clinical use of buprenorphine in opiate addiction: evidence and practice

    Acta Neuropsychiatrica

    Volume 16, Issue 5, October 2004, Pages: 246–274, Fergus D. Law, Judy S. Myles, Mark R. C. Daglish and David J. Nutt

    Version of Record online : 11 FEB 2005, DOI: 10.1111/j.0924-2708.2004.00095.x

  14. Buprenorphine implants for treatment of opioid dependence: randomized comparison to placebo and sublingual buprenorphine/naloxone

    Addiction

    Volume 108, Issue 12, December 2013, Pages: 2141–2149, Richard N. Rosenthal, Walter Ling, Paul Casadonte, Frank Vocci, Genie L. Bailey, Kyle Kampman, Ashwin Patkar, Steven Chavoustie, Christine Blasey, Stacey Sigmon and Katherine L. Beebe

    Version of Record online : 18 SEP 2013, DOI: 10.1111/add.12315

  15. Buprenorphine for the management of opioid withdrawal

    Intervention Review

    The Cochrane Library

    Linda Gowing, Robert Ali and Jason M White

    Published Online : 8 JUL 2009, DOI: 10.1002/14651858.CD002025.pub4

  16. You have free access to this content
    The clinical analgesic efficacy of buprenorphine

    Journal of Clinical Pharmacy and Therapeutics

    Volume 39, Issue 6, December 2014, Pages: 577–583, R. B. Raffa, M. Haidery, H.-M. Huang, K. Kalladeen, D. E. Lockstein, H. Ono, M. J. Shope, O. A. Sowunmi, J. K. Tran and J. V. Pergolizzi Jr

    Version of Record online : 29 JUL 2014, DOI: 10.1111/jcpt.12196

  17. You have free access to this content
    Buprenorphine: An Analgesic with an Expanding Role in the Treatment of Opioid Addiction

    CNS Drug Reviews

    Volume 8, Issue 4, December 2002, Pages: 377–390, Susan E. Robinson

    Version of Record online : 7 JUN 2006, DOI: 10.1111/j.1527-3458.2002.tb00235.x

  18. Buprenorphine versus methadone maintenance for the treatment of opioid dependence

    Addiction

    Volume 94, Issue 9, September 1999, Pages: 1337–1347, Gabriele Fischer, Wolfgang Gombas, Harald Eder, Reinhold Jagsch, Alexandra Peternell, Georg Stuhlinger, Lukas Pezawas, Harald N. Aschauer and Siegfried Kasper

    Version of Record online : 3 MAY 2002, DOI: 10.1046/j.1360-0443.1999.94913376.x

  19. You have free access to this content
    Post-marketing Surveillance of Methadone and Buprenorphine in the United States

    Pain Medicine

    Volume 11, Issue 7, July 2010, Pages: 1078–1091, Nabarun Dasgupta, Elise J. Bailey, Theodore Cicero, James Inciardi, Mark Parrino, Andrew Rosenblum and Richard C. Dart

    Version of Record online : 8 JUN 2010, DOI: 10.1111/j.1526-4637.2010.00877.x

  20. The novel depot of buprenorphine propionate has a long-acting effect on physical dependence on morphine

    Drug Development Research

    Volume 67, Issue 5, May 2006, Pages: 462–469, Kuo-Sheng Liu, Ching-Nan Lin, Ja-Ping Shieh, Chin-Chen Chu, Chun-Hsiung Kuei and Jhi-Joung Wang

    Version of Record online : 19 SEP 2006, DOI: 10.1002/ddr.20107